244 related articles for article (PubMed ID: 17854734)
1. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
[TBL] [Abstract][Full Text] [Related]
2. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
[TBL] [Abstract][Full Text] [Related]
3. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
[TBL] [Abstract][Full Text] [Related]
4. Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.
Grebely J; Raffa JD; Meagher C; Duncan F; Genoway KA; Khara M; McLean M; Mead A; Viljoen M; DeVlaming S; Fraser C; Conway B
J Gastroenterol Hepatol; 2007 Sep; 22(9):1519-25. PubMed ID: 17645460
[TBL] [Abstract][Full Text] [Related]
5. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.
Grebely J; Knight E; Genoway KA; Viljoen M; Khara M; Elliott D; Gallagher L; Storms M; Raffa JD; DeVlaming S; Duncan F; Conway B
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):270-7. PubMed ID: 20425880
[TBL] [Abstract][Full Text] [Related]
6. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
[TBL] [Abstract][Full Text] [Related]
8. Current approaches to HCV infection in current and former injection drug users.
Grebely J; deVlaming S; Duncan F; Viljoen M; Conway B
J Addict Dis; 2008; 27(2):25-35. PubMed ID: 18681189
[TBL] [Abstract][Full Text] [Related]
9. Delivering care to injection drug users coinfected with HIV and hepatitis C virus.
Taylor LE
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S355-61. PubMed ID: 15768348
[TBL] [Abstract][Full Text] [Related]
10. Approaching treatment for hepatitis C virus infection in substance users.
Sylvestre DL
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S79-82. PubMed ID: 16265620
[TBL] [Abstract][Full Text] [Related]
11. Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
Soriano V; Ramos B; Nunez M; Barreiro P; Maida I; Garcia-Samaniego J; Gonzalez-Lahoz J
J Infect Dis; 2005 Oct; 192(7):1245-8. PubMed ID: 16136468
[TBL] [Abstract][Full Text] [Related]
12. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
Dore GJ; Thomas DL
Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.
Guadagnino V; Trotta MP; Montesano F; Babudieri S; Caroleo B; Armignacco O; Carioti J; Maio G; Monarca R; Antinori A;
Addiction; 2007 Mar; 102(3):423-31. PubMed ID: 17298650
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.
Litwin AH; Berg KM; Li X; Hidalgo J; Arnsten JH
BMC Infect Dis; 2011 Nov; 11():315. PubMed ID: 22078241
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis C infection for current or former substance abusers in a community setting.
John-Baptiste A; Varenbut M; Lingley M; Nedd-Roderique T; Teplin D; Tomlinson G; Daiter J; Krahn M
J Viral Hepat; 2009 Aug; 16(8):557-67. PubMed ID: 19243498
[TBL] [Abstract][Full Text] [Related]
17. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.
Dalgard O; Bjøro K; Hellum K; Myrvang B; Skaug K; Gutigard B; Bell H;
Eur Addict Res; 2002 Jan; 8(1):45-9. PubMed ID: 11818693
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
Grebely J; Petoumenos K; Matthews GV; Haber P; Marks P; Lloyd AR; Kaldor JM; Dore GJ; Hellard M;
Drug Alcohol Depend; 2010 Mar; 107(2-3):244-9. PubMed ID: 19926405
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatitis C in HIV infected and other immunocompromised individuals.
Seth AK
Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
